Associations of dietary flavones, particularly apigenin and luteolin, with phenotypic age acceleration: A cross-sectional study using NHANES data

Specific flavone subclasses, particularly apigenin and luteolin, exhibit potent anti-aging properties mediated by their anti-inflammatory and antioxidant activities. However, epidemiological evidence relating these bioactive compounds to phenotypic age acceleration (PhenoAgeAccel) remains limited. We analyzed data from 10,789 US adults participating in the National Health and Nutrition Examination Survey 2007-2010 and 2017-2018 cycles. PhenoAgeAccel was calculated as the residuals from regressing phenotypic age (based on inflammatory and metabolic biomarkers) on chronological age, where positive values indicated accelerated aging. Intakes of total flavones, apigenin, and luteolin were quantified using 24-h dietary recalls. Weighted multivariable logistic regression models were used to assess associations between flavone intakes and PhenageAccel, with comprehensive adjustments for potential confounders. Restricted cubic spline models were employed to evaluate non-linear relationships. Higher total flavone intake was associated with a dose-dependent decrease in PhenoAgeAccel (P-trend < .001). In fully adjusted models, each log-unit increase (equivalent to 2.7-fold higher intake) in flavone intake corresponded to a 9.6% reduction in the odds of PhenoAgeAccel (odds ratio [OR] = 0.904, 95% confidence interval: 0.859-0.953). Similar inverse associations were observed for apigenin (Q4 vs Q1: OR = 0.647, P = .002) and luteolin (Q4 vs Q1: OR = 0.736, P = .011). Significant non-linear dose-response relationships were observed for all flavones (P-nonlinearity < 0.001). Subgroup analyses unveiled consistent associations across age, sex, and cardiometabolic status (all P-interaction > 0.05). In this nationally representative sample, higher dietary intakes of flavones, particularly apigenin and luteolin, were strongly associated with reduced PhenoAgeAccel. These findings suggest the potential role of flavones as modifiable dietary factors for healthy aging.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2025-12-12
DOI
https://doi.org/10.1097/md.0000000000046520
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations of dietary flavones, particularly apigenin and luteolin, with phenotypic age acceleration: A cross-sectional study using NHANES data

Peijia Liu, Wujian Peng, Shujuan Tian, Guixia Li et al.
Medicine
Flavonoids in Medical Research
article

Associations of dietary flavones, particularly apigenin and luteolin, with phenotypic age acceleration: A cross-sectional study using NHANES data

Peijia Liu, Wujian Peng, Shujuan Tian, Guixia Li, Chang Liu, Xuechao Wang
article en

Abstract

Specific flavone subclasses, particularly apigenin and luteolin, exhibit potent anti-aging properties mediated by their anti-inflammatory and antioxidant activities. However, epidemiological evidence relating these bioactive compounds to phenotypic age acceleration (PhenoAgeAccel) remains limited. We analyzed data from 10,789 US adults participating in the National Health and Nutrition Examination Survey 2007-2010 and 2017-2018 cycles. PhenoAgeAccel was calculated as the residuals from regressing phenotypic age (based on inflammatory and metabolic biomarkers) on chronological age, where positive values indicated accelerated aging. Intakes of total flavones, apigenin, and luteolin were quantified using 24-h dietary recalls. Weighted multivariable logistic regression models were used to assess associations between flavone intakes and PhenageAccel, with comprehensive adjustments for potential confounders. Restricted cubic spline models were employed to evaluate non-linear relationships. Higher total flavone intake was associated with a dose-dependent decrease in PhenoAgeAccel (P-trend < .001). In fully adjusted models, each log-unit increase (equivalent to 2.7-fold higher intake) in flavone intake corresponded to a 9.6% reduction in the odds of PhenoAgeAccel (odds ratio [OR] = 0.904, 95% confidence interval: 0.859-0.953). Similar inverse associations were observed for apigenin (Q4 vs Q1: OR = 0.647, P = .002) and luteolin (Q4 vs Q1: OR = 0.736, P = .011). Significant non-linear dose-response relationships were observed for all flavones (P-nonlinearity < 0.001). Subgroup analyses unveiled consistent associations across age, sex, and cardiometabolic status (all P-interaction > 0.05). In this nationally representative sample, higher dietary intakes of flavones, particularly apigenin and luteolin, were strongly associated with reduced PhenoAgeAccel. These findings suggest the potential role of flavones as modifiable dietary factors for healthy aging.

MedicineVol. 104(50)
Southern University of Science and Technology (CN), Shenzhen Second People's Hospital (CN), Shenzhen Third People’s Hospital (CN)
Openalex Percentile: Top 57%
Flavonoids in Medical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.